Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity
- 28 June 2008
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 65, S253-S259
- https://doi.org/10.1111/j.1753-4887.2007.tb00372.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward ConsensusPublished by Elsevier ,2007
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Inflammation and cardiovascular disease mechanismsThe American Journal of Clinical Nutrition, 2006
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Prevalence of Conventional Risk Factors in Patients With Coronary Heart DiseaseJAMA, 2003
- Inflammation in atherosclerosisNature, 2002
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997